
    
      The overall goal of this protocol is to evaluate the biodistribution of [18F]MNI-968 as a D1
      receptor targeted radiopharmaceutical. The specific objectives are:

        -  To determine the radiation dosimetry of [18F]MNI-968

        -  To assess the safety and tolerability of a single dose of [18F]MNI-968
    
  